DEDavid Erren

David Erren

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


David Erren has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Preoperative C-Reactive Protein-to-Albumin Ratio Predicts Recipient and Graft Survival After Deceased-Donor Liver Transplantation

    by David Erren, Franziska A. Meister, Karsten Große, Tony Bruns, Naomi Gestels, Oliver Beetz, Felix Oldhafer, Martin W. von Websky, Thomas Vogel, Florian W. R. Vondran, et al.

    Background/Objectives: Recipient-related factors continue to influence long-term outcomes after deceased-donor liver transplantation (DDLT). This study evaluated the prognostic value of the preoperative C-reactive protein-to-albumin ratio (CAR) for recipient survival (RS) and graft survival (GS). Methods: Adult patients undergoing DDLT between 2010 and 2023 were retrospectively analyzed. Re-transplantations, split or domino transplants, patients who died within 90 days and patients with early allograft dysfunction were excluded. Primary endpoints were 3-year RS and GS. Receiver operating characteristic analysis was used to determine the optimal CAR cut-off. Survival was assessed using Kaplan–Meier analysis and Cox regression. Results: A total of 330 patients were included. Mean RS and GS were 112 months (95%CI 106–119) and 110 months (95%CI 103–116), respectively. Preoperative CAR demonstrated the strongest predictive value for 3-year RS (AUC = 0.70, p < 0.001) and GS (AUC = 0.71, p < 0.001). A CAR cut-off of 41% provided optimal discrimination. Patients with CAR > 41% had significantly reduced 3-year RS (31 vs. 34 months, p < 0.001) and GS (30 vs. 34 months, p < 0.001). CAR > 41% was independently associated with increased risk of 3-year mortality (HR 2.101, 95%CI 1.277–3.456, p = 0.003) and graft loss (HR 3.666, 95%CI 1.804–7.449, p < 0.001). Similar results were observed for 5-year outcomes. Conclusions: Elevated preoperative CAR is independently associated with inferior patient and graft survival and may enhance risk stratification after DDLT.